BACKGROUND: The US Preventive Services Task Force recommends against spirometry in the absence of symptoms. However, as much as 50% of COPD cases in the United States remain undiagnosed. METHODS: Report of symptoms, smoking history, and spirometric data were collected from subjects screened for a work-related medical evaluation (N = 3,955). Prevalence of airflow obstruction and respiratory symptoms were assessed. Sensitivity, specificity, positive and negative predictive values, and relative risks of predicting symptoms and smoking history for COPD were calculated. RESULTS: Forty-four percent of smokers in our sample had airways obstruction (AO). Of these, 36% reported a diagnosis of or treatment for COPD. Odds ratio (95% CI) for AO with smoking (> or = 20 pack-years) was 3.73 (3.12- 4.45), 1.98 (1.73-2.27) for cough, 1.79 (1.55-2.08) for dyspnea, 1.95 (1.70-2.34) for sputum, and 2.59 (2.26-2.97) for wheeze. Respiratory symptoms were reported by 92% of smokers with AO, 86% smokers with restriction, 76% smokers with normal spirometry, and 73% of nonsmokers. Sensitivity (92% vs 90%), specificity (19% vs 22%), positive (47% vs 40%) and negative (75% vs 80%) predictive values for the presence of one or more symptoms were similar between smokers and all subjects. CONCLUSIONS: COPD is underdiagnosed in the United States. Symptoms are frequent in subjects with AO and increase their risk for COPD, but add little beyond age and smoking history to the predictive value of spirometry. In view of the high prevalence of symptoms and their poor predictive value, a simpler and more effective approach would be to screen older smokers.
BACKGROUND: The US Preventive Services Task Force recommends against spirometry in the absence of symptoms. However, as much as 50% of COPD cases in the United States remain undiagnosed. METHODS: Report of symptoms, smoking history, and spirometric data were collected from subjects screened for a work-related medical evaluation (N = 3,955). Prevalence of airflow obstruction and respiratory symptoms were assessed. Sensitivity, specificity, positive and negative predictive values, and relative risks of predicting symptoms and smoking history for COPD were calculated. RESULTS: Forty-four percent of smokers in our sample had airways obstruction (AO). Of these, 36% reported a diagnosis of or treatment for COPD. Odds ratio (95% CI) for AO with smoking (> or = 20 pack-years) was 3.73 (3.12- 4.45), 1.98 (1.73-2.27) for cough, 1.79 (1.55-2.08) for dyspnea, 1.95 (1.70-2.34) for sputum, and 2.59 (2.26-2.97) for wheeze. Respiratory symptoms were reported by 92% of smokers with AO, 86% smokers with restriction, 76% smokers with normal spirometry, and 73% of nonsmokers. Sensitivity (92% vs 90%), specificity (19% vs 22%), positive (47% vs 40%) and negative (75% vs 80%) predictive values for the presence of one or more symptoms were similar between smokers and all subjects. CONCLUSIONS:COPD is underdiagnosed in the United States. Symptoms are frequent in subjects with AO and increase their risk for COPD, but add little beyond age and smoking history to the predictive value of spirometry. In view of the high prevalence of symptoms and their poor predictive value, a simpler and more effective approach would be to screen older smokers.
Authors: Eva Balcells; Josep M Antó; Joaquim Gea; Federico P Gómez; Esther Rodríguez; Alicia Marin; Antoni Ferrer; Jordi de Batlle; Eva Farrero; Marta Benet; Mauricio Orozco-Levi; Jaume Ferrer; Alvar G Agustí; Juan B Gáldiz; José Belda; Judith Garcia-Aymerich Journal: Respir Med Date: 2009-05-08 Impact factor: 3.415
Authors: S Rennard; M Decramer; P M A Calverley; N B Pride; J B Soriano; P A Vermeire; J Vestbo Journal: Eur Respir J Date: 2002-10 Impact factor: 16.671
Authors: Bartolome Celli; Marc Decramer; Steven Kesten; Dacheng Liu; Sunil Mehra; Donald P Tashkin Journal: Am J Respir Crit Care Med Date: 2009-09-03 Impact factor: 21.405
Authors: Mary B Rice; Petter L Ljungman; Elissa H Wilker; Diane R Gold; Joel D Schwartz; Petros Koutrakis; George R Washko; George T O'Connor; Murray A Mittleman Journal: Am J Respir Crit Care Med Date: 2013-12-01 Impact factor: 21.405
Authors: Matthew L Mintz; Barbara P Yawn; David M Mannino; James F Donohue; Nicola A Hanania; Catherine A Grellet; Alicia W Gilsenan; Lori D McLeod; Anand A Dalal; Ibrahim H Raphiou; Barbara A Prillaman; Glenn D Crater; Michael J Cicale; Douglas W Mapel Journal: Mayo Clin Proc Date: 2011-05 Impact factor: 7.616
Authors: Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera Journal: Lung India Date: 2013-07
Authors: Anamika Jithoo; Paul L Enright; Peter Burney; A Sonia Buist; Eric D Bateman; Wan C Tan; Michael Studnicka; Filip Mejza; Suzanne Gillespie; William M Vollmer Journal: Eur Respir J Date: 2012-06-27 Impact factor: 16.671
Authors: Roy A Pleasants; Khosrow Heidari; Anne G Wheaton; Jill A Ohar; Charlie Strange; Janet B Croft; Winston Liao; David M Mannino; Monica Kraft Journal: COPD Date: 2015-09-14 Impact factor: 2.409
Authors: MeiLan K Han; Anna W Steenrod; Elizabeth D Bacci; Nancy K Leidy; David M Mannino; Byron M Thomashow; R G Barr; Barry J Make; Russ P Bowler; Stephen I Rennard; Julia F Houfek; Barbara P Yawn; Catherine A Meldrum; John W Walsh; Fernando J Martinez Journal: Chronic Obstr Pulm Dis Date: 2015